Home
Litigation

Work Area: Litigation

Blackberry patent buyer’s US litigation track record

Key Patent Innovations has a scant history of suing in the States, indicating its licensing approach may centre on private negotiations in contrast to the failed purchaser

Ericsson and Nokia v Oppo signal that non-discriminatory terms are key concern for Indian courts

Recent case law, along with the trend for out-of-court settlements between SEP holders and mobile manufacturers, highlights that the non-discriminatory part of ‘FRAND’ is being treated as a priority right now.

NuCana’s big-money damages hopes suffer blow as UK court backs Gilead in European dispute

The High Court of England and Wales has shifted the momentum of the spat, with the EPO Technical Board of Appeal set to hear a related case tomorrow

Latest content

Top 10 FRAND developments of 2022

These new patent pools, global litigation developments, and SEP policy changes will keep making waves in the New Year

21 December 2022

An almost billion-dollar award leads 2022’s top 10 US patent verdicts

Companies who scored the most from US juries during the past 12 months include VLSI Technology, Complete Genomics Inc, Ravgen Inc, USAA and Columbia University

19 December 2022

Five of the US patent world’s biggest news nuggets of 2022

Intel sold 5,000 patents to an NPE, Apple signed up for two multi-million dollar SEP licences, Kathi Vidal made her mark as USPTO director – and more

15 December 2022

The legitimate source defence and why it is good news for defendants in patent infringement disputes

The Intellectual Property Court of the Supreme People’s Court has zeroed in on Renhengde v Huzhou Aixin & Huzhou MCHC Hospital to clarify the criteria of the legitimate source defence, offering a way out of damages liability.

14 December 2022

Data shows New Jersey district court’s key for biopharma patent litigation

We have scoured Docket Navigator for must-know metrics on case filing trends, rulings on important motions, injunctive relief and damages awards

12 December 2022

2022’s pendulum oscillations at the PTAB

USPTO director’s eight-month tenure this year saw tweaks to discretionary denials and applicant-admitted prior art – to the pleasure of the anti-patent community

09 December 2022